Gilead Sciences Inc
Stock Chart, Company Information, and Scan Results
$112.50(as of Sep 22, 3:59 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Gilead Sciences Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$112.50
Ticker SymbolGILD
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees17,600
CountyUSA
Market Cap$141,563.7M
EBIDTA13,801.0M
10-Day Moving Average113.61
P/E Ratio22.37
20-Day Moving Average113.30
Forward P/E Ratio13.18
50-Day Moving Average113.40
Earnings per Share5.04
200-Day Moving Average104.75
Profit Margin27.68%
RSI46.75
Shares Outstanding1,240.8M
ATR2.39
52-Week High120.99
Volume7,256,896
52-Week Low79.46
Book Value19,591.0M
P/B Ratio7.21
Upper Keltner118.67
P/S Ratio4.89
Lower Keltner107.93
Debt-to-Equity Ratio118.67
Next Earnings Date10/23/2025
Cash Surplus-6,045.0M
Next Ex-Dividend DateUnknown
Add good karma to your portfolio with GILD. This research-based biopharmaceutical company is making the world a better place by developing and commercializing medicines for life-threatening diseases like HIV/AIDS, liver diseases, and cancer. Gilead’s HIV treatments, including Truvada and Atripla, have helped transform the chronic disease into a manageable condition. Their treatments are responsible for saving millions of lives.
Gilead Sciences Inc In Our Stock Scanner
As of Sep 23, 2025
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.